How does verteporfin actually stop leaking blood vessels in the eye?
Verteporfin is a light-activated dye that generates reactive oxygen molecules when exposed to nonthermal red light. These molecules damage the walls of abnormal blood vessels, sealing them shut within 48 hours [1].
Here's the federal trial truth: verteporfin is transported through your bloodstream by lipoproteins (fat-carrying proteins). Once the ophthalmologist shines red light on the back of your eye exactly 15 minutes after injection, the drug transforms into a powerful oxygen-releasing molecule. This reactive oxygen damages the endothelial cells lining the leaky vessels, causing them to clot and close [1].
Think of it like a chemical light switch inside your eye. The drug alone does nothing—it's inert, harmless. But when red light hits it, the drug becomes a tiny oxygen bomb that only damages the abnormal vessels you're targeting. Normal, healthy blood vessels are spared because the light is focused precisely on the problem area [1].
The real-world trade-off is timing. You must have the light activation within 15 minutes of injection, or the drug loses its power. You'll also need to avoid sunlight and bright indoor light for 48 hours afterward, because any light can activate leftover verteporfin in your skin and cause burns. Plan your treatment for late afternoon so you can go home and rest in dim light [1].
Ask your ophthalmologist: 'Will you do the light activation in your office right after the injection, or do I need to go to a separate facility?' This determines whether you're done in 90 minutes or need two appointments.